UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review

Expert opinion on drug metabolism & toxicology, 2022-11, Vol.18 (11), p.715-727

2022

Volltextzugriff (PDF)

A Clinical Pharmacology and Therapeutics Teacher's Guide to Race‐Based Medicine, Inclusivity, and Diversity

Clinical pharmacology and therapeutics, 2023-03, Vol.113 (3), p.600-606

2023

Volltextzugriff (PDF)

Data From the World Health Organization's Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions

Schizophrenia bulletin, 2020-01, Vol.46 (1), p.1-3

2020

Volltextzugriff (PDF)

Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)

Schizophrenia research, 2024-06, Vol.268, p.165-174

2024

Volltextzugriff (PDF)

Neurodevelopmental Outcomes among Brazilian Children with Cyanotic Congenital Heart Disease and Its Associated Factors

Medicina (Kaunas, Lithuania), 2022-11, Vol.58 (11), p.1669

2022

Volltextzugriff (PDF)

European List of Essential Medicines for Medical Education: a protocol for a modified Delphi study

BMJ open, 2021-05, Vol.11 (5), p.e045635-e045635

2021

Volltextzugriff (PDF)

Functional Status of Patients over 65 Years Old Intervened on for a Hip Fracture One Year after the Operation

Healthcare (Basel), 2023-05, Vol.11 (10), p.1520

2023

Volltextzugriff (PDF)

Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database

Schizophrenia research, 2024-06, Vol.268, p.118-130

2024

Volltextzugriff (PDF)

Teaching resources for the European Open Platform for Prescribing Education (EurOP2E) : a nominal group technique study

NPJ science of learning, 2022-09, Vol.7 (1), p.23-23, Article 23

2022

Volltextzugriff (PDF)

Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychotics

World psychiatry, 2020-02, Vol.19 (1), p.120-121

2020

Volltextzugriff (PDF)

Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase

Expert review of clinical pharmacology, 2022-01, Vol.15 (1), p.65-78

2022

Volltextzugriff (PDF)

Analysis of deprescription strategies of proton pump inhibitors in primary care: a narrative review

Primary health care research & development, 2023-02, Vol.24, p.e14, Article e14

2023

Volltextzugriff (PDF)

Respiratory aspiration during treatment with benzodiazepines, antiepileptic and antidepressant drugs in the pharmacovigilance database from VigiBase

Expert opinion on drug metabolism & toxicology, 2022-09, Vol.18 (9), p.541-553

2022

Volltextzugriff (PDF)

Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries

Revista de psiquiatria y salud mental (English ed.), 2022-10, Vol.15 (4), p.238-250

2022

Volltextzugriff (PDF)

The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase

Psychological medicine, 2021-06, Vol.51 (8), p.1405-1406

2021

Volltextzugriff (PDF)

Risk factors for non-adherence to antidepressant treatment in patients with mood disorders

European journal of clinical pharmacology, 2014, Vol.70 (1), p.89-98

2014

Volltextzugriff (PDF)

Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK

Schizophrenia research, 2024-06, Vol.268, p.175-188

2024

Volltextzugriff (PDF)

Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase

Expert opinion on drug metabolism & toxicology, 2023-02, Vol.19 (2), p.57-74

2023

Volltextzugriff (PDF)

An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance

Schizophrenia research, 2024-06, Vol.268, p.60-65

2024

Volltextzugriff (PDF)

An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance

Schizophrenia research, 2024-06, Vol.268, p.53-59

2024

Volltextzugriff (PDF)

Polypharmacy in psychiatric practice in the Canary Islands

BMC psychiatry, 2004-07, Vol.4 (1), p.18-18, Article 18

2004

Volltextzugriff (PDF)

The European Prescribing Exam: assessing whether European medical students can prescribe rationally and safely

European journal of clinical pharmacology, 2022-06, Vol.78 (6), p.1049-1051

2022

Volltextzugriff (PDF)

Clozapine and the risk of haematological malignancies

The Lancet. Psychiatry, 2022-07, Vol.9 (7), p.537-538

2022

Volltextzugriff (PDF)

Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia

Expert opinion on drug metabolism & toxicology, 2024-08, Vol.20 (8), p.857-871

2024

Volltextzugriff (PDF)

Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature

Expert opinion on drug safety, 2024-09, p.1-11

2024

Volltextzugriff (PDF)

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(210)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review

A Clinical Pharmacology and Therapeutics Teacher's Guide to Race‐Based Medicine, Inclusivity, and Diversity

Data From the World Health Organization's Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions

Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)

Neurodevelopmental Outcomes among Brazilian Children with Cyanotic Congenital Heart Disease and Its Associated Factors

European List of Essential Medicines for Medical Education: a protocol for a modified Delphi study

Functional Status of Patients over 65 Years Old Intervened on for a Hip Fracture One Year after the Operation

Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database

Teaching resources for the European Open Platform for Prescribing Education (EurOP2E) : a nominal group technique study

Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychotics

Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase

Analysis of deprescription strategies of proton pump inhibitors in primary care: a narrative review

Respiratory aspiration during treatment with benzodiazepines, antiepileptic and antidepressant drugs in the pharmacovigilance database from VigiBase

Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries

The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase

Risk factors for non-adherence to antidepressant treatment in patients with mood disorders

Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK

Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase

An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance

An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance

Polypharmacy in psychiatric practice in the Canary Islands

The European Prescribing Exam: assessing whether European medical students can prescribe rationally and safely

Clozapine and the risk of haematological malignancies

Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia

Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature

Suchergebnisse filtern